Healthcare

This research service presents an overview of the South Korean biosimilars market and analyzes the opportunities that lay ahead for different stakeholders in the development, manufacturing, and commercialization of biosimilars. This service divides the market into therapeutic proteins and monoclonal antibodies. Further, it aims to present an overvi...

This study provides a comprehensive analysis of the contract research and manufacturing services (CRAMS) segment in India by focusing on drug discovery to pre-clinical toxicology, Active Pharmaceutical Ingredient (API), Formulations and Injectables. The study is based on detailed primary research, and includes an evaluation of the market size as ...

The continuing convergence of healthcare and information communication technologies makes the telehealth industry one of the most confusing yet transformative spaces in the world. Despite many hurdles, telehealth markets continue to be an effective treatment for many shortfalls present in the current healthcare experience, whether it is getting to...

This research service covers the therapeutics for rheumatic diseases market in the United States from 2009 to 2017, with 2011 as the base year. The focus of this research is on biologics and other treatments prescribed as add-on therapies for rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS); background standard ...

This research service considers products and companies in the obesity surgery devices market in the United States. The market is expected to see many technology advancements in the next decade. Therefore, a thorough understanding of revenue forecasts, unit forecasts, technological advances, and pricing analyses are provided for the markets various...

This deliverable provides insights on the many macro issues facing the life sciences industry which have resulted in consolidation and an increasing number in partnerships. This research service presents merger and acquisition activity by select life sciences participants and business strategies for new drug development, including contract research...

This issue of Vital Signs, released on August 20, 2012, discusses perspectives of different Frost & Sullivan analysts on recent noteworthy news items for various markets including Life Sciences, Advanced Medical Technology and Connected Health.

This issue of Vital Signs, released on August 13, 2012, provides an insight in to the recent advancements in drug delivery. Additionally, a company spotlight is provided for Ratio. Ratio, Inc. is a start-up company focused on the development of a novel hydrogel-powered injectable drug delivery device that is worn like a patch. Reimbursement a...

This study examines the key trends and issues affecting the U.S. hospital health data analytics market, including a review of industry challenges and market drivers and restraints through 2016. It also analyzes the impact of recent legislative mandates on the implementation and usage of information technology, including data analytics, in U.S. hos...